B Cell‐Activating Factor Enhances Interleukin‐6 and Interleukin‐10 Production by ODN‐Activated Human B Cells
Dana Yehudai(University Health Network), Aharon Kessel(Technion – Israel Institute of Technology), Tharwat Haj(Technion – Israel Institute of Technology), Ayelet Snir(Technion – Israel Institute of Technology), Katalin Halasz(Bnai Zion Medical Center), Regina Peri(Technion – Israel Institute of Technology), M. Odeh(Bnai Zion Medical Center)
Cited by 27
Related Papers
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients
|Allergy|2004|301
Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells
|Autoimmunity Reviews|2011|293
Intravenous Immunoglobulin Therapy Affects T Regulatory Cells by Increasing Their Suppressive Function
|The Journal of Immunology|2007|229
Age-related autoimmunity
|BMC Medicine|2013|196